Brief: Eversana Selected By Innovacell As Commercialization Partner To Advance Novel Cell Therapy Icef15 In The United States
30/07/2026 13:06
BRIEF-Eversana Selected By Innovacell As Commercialization Partner To Advance Novel Cell Therapy Icef15 In The United States July 30 (Reuters) - Innovacell Inc 504A.T:
EVERSANA SELECTED BY INNOVACELL AS COMMERCIALIZATION PARTNER TO ADVANCE NOVEL CELL THERAPY ICEF15 IN THE UNITED STATES
Source text: ID:nPn4Bh5Bwa
Further company coverage: 504A.T